BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3326696)

  • 21. Baroreflexes and cardiovascular regulation in hypertension.
    Head GA
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S7-16. PubMed ID: 8642810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension.
    Moretti JL; Burke SL; Evans RG; Lambert GW; Head GA
    J Hypertens; 2009 Sep; 27(9):1838-48. PubMed ID: 19512943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autonomic nervous system in arterial hypertension].
    Grassi G
    Ital Heart J Suppl; 2001 Aug; 2(8):850-6. PubMed ID: 11582717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contribution of the sympathetic nervous system to hypertension in diabetes mellitus.
    Kribben A; Philipp T
    Diabete Metab; 1989; 15(5 Pt 2):313-7. PubMed ID: 2693150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats.
    Takenaka K; Sasaki S; Uchida A; Fujita H; Nakamura K; Ichida T; Itoh H; Nakata T; Takeda K; Nakagawa M
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):964-72. PubMed ID: 8896648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sympathetic nervous system in human hypertension.
    Mancia G; Grassi G; Parati G; Zanchetti A
    Acta Physiol Scand Suppl; 1997; 640():117-21. PubMed ID: 9401621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of calcium antagonists on sympathetic activity.
    Grossman E; Messerli FH
    Eur Heart J; 1998 Jun; 19 Suppl F():F27-31. PubMed ID: 9651732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release.
    Esler MD; Jennings GL; Johns J; Burke F; Little PJ; Leonard P
    J Hypertens Suppl; 1984 Dec; 2(3):S123-5. PubMed ID: 6599657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension.
    Fagard RH; Stolarz K; Kuznetsova T; Seidlerova J; Tikhonoff V; Grodzicki T; Nikitin Y; Filipovsky J; Peleska J; Casiglia E; Thijs L; Staessen JA; Kawecka-Jaszcz K
    J Hypertens; 2007 Nov; 25(11):2280-5. PubMed ID: 17921823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study.
    Tewari HK; Gadia R; Kumar D; Venkatesh P; Garg SP
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3474-8. PubMed ID: 16877418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activity of sympatho-adrenal system in essential hypertension patients].
    Lohmann FW; Dissmann T; Gotzen R; Molzahn M; Schröder G
    Verh Dtsch Ges Inn Med; 1973; 79():809-12. PubMed ID: 4790003
    [No Abstract]   [Full Text] [Related]  

  • 35. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dopamine-beta-hydroxylase activity and catecholamine concentration in plasma as a parameter of sympathetic tonus: effect of the ergometric test on patients with normotension and essential hypertension].
    Planz G; Corr H; Gierlichs HW; Hawlina A; Planz R; Stephany W; Rahn KH
    Verh Dtsch Ges Inn Med; 1975; 81():1066-8. PubMed ID: 1229400
    [No Abstract]   [Full Text] [Related]  

  • 37. The sympatho-adrenal tone and reactivity in human hypertension.
    de Champlain J; Gonzalez M; Lebeau R; Eid H; Petrovitch M; Nadeau RA
    Clin Exp Hypertens A; 1989; 11 Suppl 1():159-71. PubMed ID: 2663246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Symphathetic activity in labile essential hypertension in young men. Part II. Influence of exercise on plasma catecholamines.
    Rysánek K; Prikryl P; Kvetnanský R; Kunovská V; Rechtoríková O; Dohnalová I
    Act Nerv Super (Praha); 1982 Mar; 24(1):30-1. PubMed ID: 7090720
    [No Abstract]   [Full Text] [Related]  

  • 39. Borderline hypertension. Circulatory, sympatho-adrenal and psychological reactions to stress.
    Eliasson K
    Acta Med Scand Suppl; 1985; 692():1-90. PubMed ID: 3883705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial catecholamines and the pathophysiology of heart failure.
    Daly PA; Sole MJ
    Circulation; 1990 Aug; 82(2 Suppl):I35-43. PubMed ID: 2197023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.